Clik here to view.
Akili Enters Strategic Licensing Agreement with TALi, Extending Akili...
BOSTON & MELBOURNE, Australia Akili Interactive (“Akili”), a leading prescription digital therapeutics company and maker of EndeavorRx®, the first and only prescription video game treatment, and...
View ArticleClik here to view.
Ranok Therapeutics Secures $40 Million Series B Financing to Advance its...
BOSTON & HANGZHOU, China Ranok Therapeutics (Hangzhou) Co. Ltd., an emerging biopharmaceutical company focused on developing breakthrough therapies for cancer and other serious diseases, today...
View ArticleClik here to view.
Curia to Expand U.S. Commercial Manufacturing Capability
ALBANY, N.Y. Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today announced plans to expand its commercial manufacturing capacity at its Rensselaer,...
View ArticleClik here to view.
Regencell Bioscience Holdings Limited Announces Partial Exercise of...
HONG KONG Regencell Bioscience Holdings Limited (NASDAQ:RGC) (“Regencell” or the “Company”), an early-stage bioscience company that focuses on research, development and commercialization of...
View ArticleClik here to view.
ゾールとワラビー・メディカルが中国における温度管理製品の販売契約を発表
米マサチューセッツ州チェルムズフォード （ビジネスワイヤ） — 旭化成傘下で医療機器と関連ソフトウエアソリューションを製造するゾール・メディカル・コーポレーションと、脳卒中と心停止の治療に専心する医療機器企業のワラビー・メディカル・テクノロジーズは本日、販売契約を締結し、ワラビーが中国におけるゾールの温度管理製品の販売・流通を運営すると発表しました。...
View ArticleClik here to view.
ZOLL和Wallaby Medical宣布达成在中国分销体温管理产品的协议
马萨诸塞州切尔姆斯福德 (美国商业资讯)–旭化成(Asahi Kasei)旗下主营医疗器械制造和相关软件解决方案的ZOLL® Medical Corporation和致力于治疗卒中和心脏骤停的医疗器械公司Wallaby Medical Technologies今天宣布，双方已签署分销协议，Wallaby将负责在中国销售和分销ZOLL的体温管理产品。...
View ArticleClik here to view.
FDA、世界最小の心臓ポンプImpella ECPを画期的医療機器に指定
米マサチューセッツ州ダンバース （ビジネスワイヤ） — 米国食品医薬品局（FDA）は、アビオメッド（NASDAQ: ABMD）の拡張型経皮的心臓ポンプImpella ECPを画期的医療機器に指定しました。この指定は、FDAが設計反復、臨床試験プロトコル、市販前承認（PMA）の申請を含むImpella ECPの規制当局の審査プロセスを優先することを意味します。...
View ArticleClik here to view.
自発呼吸している血液透析患者における体液量状態のモニタリングでMasimo PVi®の使用を評価した新研究
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、Turkish Journal of Emergency Medicine誌に掲載された研究の知見について発表しました。本研究では、トルコのアンカラにあるケシオレン研修研究病院のSeda DağarおよびHüseyin...
View ArticleClik here to view.
Workplace wellbeing culture and vaccination policies impacting Australians’...
MELBOURNE, Australia LifeWorks, a leading provider of digital total wellbeing solutions, today released its monthly Mental Health Index™, revealing a negative mental-health score among Australians...
View ArticleClik here to view.
Applications of Bioluminescent Research Tools Showcased at Global Seminar Series
MADISON, Wis. Life science and drug discovery researchers interested in bioluminescent tools will have the opportunity to hear from global thought leaders on the possibilities and applications of...
View ArticleClik here to view.
World Economic Forum Names Glocal Healthcare, an UpHealth, Inc. Company, to...
KOLKATA, India & DELRAY BEACH, Fla. UpHealth, Inc. (NYSE: UPH), a healthcare leader pioneering connected digital care communities with technology, infrastructure and services to support...
View ArticleClik here to view.
Flat Medical Selected to Exhibit EpiFaith® for Epidural at Vizient Innovative...
TAIPEI, Taiwan Flat Medical has been selected to exhibit EpiFaith® Syringe, a visualization solution for epidural safety, at the Vizient Innovative Technology Exchange. Vizient, Inc, the nation’s...
View ArticleClik here to view.
Merck’s KEYTRUDA® (pembrolizumab) Receives Two New Approvals in Japan
KENILWORTH, N.J. Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck’s anti-PD-1 therapy, has received two new approvals from the Japan...
View ArticleClik here to view.
DKT International Publishes 2020 Contraceptive Social Marketing Statistics
WASHINGTON DKT International, one of the largest providers of sexual and reproductive health products and services in the developing world, is proud to announce the release of the 2020 Contraceptive...
View ArticleClik here to view.
Astex Pharmaceuticals Presents Overall Survival Data From ASCERTAIN Phase 3...
PLEASANTON, Calif. Astex Pharmaceuticals, Inc., a wholly owned subsidiary of Otsuka Pharmaceutical Co. Ltd., based in Tokyo, Japan, today announced updated clinical data, including median overall...
View ArticleClik here to view.
KUNIHIKO HIRABAYASHI Appointed as the Secretary General of ASEAN-Japan Centre
TOKYO The ASEAN-Japan Centre (AJC) is pleased to announce the appointment of Mr. Kunihiko Hirabayashi as the Secretary General of the AJC in Tokyo as of September 1, 2021. This press release...
View ArticleClik here to view.
Rhizen PharmaceuticalsがCovid-19患者でRP7214を検討する第2相試験で最初の患者への投与を発表
スイス・バーゼル （ビジネスワイヤ） — オンコロジー・炎症分野に傾注する臨床段階のバイオ製薬企業であるRhizen Pharmaceuticals...
View ArticleClik here to view.
达沃斯阿尔茨海默病合作组织和世界经济论坛宣布全球抗击阿尔茨海默病取得重大里程碑
日内瓦 (美国商业资讯)–达沃斯阿尔茨海默病合作组织(DAC)是一个动员全世界对抗阿尔茨海默病的全球多方利益相关者合作组织。DAC今天宣布，它已接近完成基础阶段的筹资，并启动了几项关键举措，以促进阿尔茨海默病的研究、预防和护理，从而推进与该疾病的斗争。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Long-Term CRYSVITA® ▼ (burosumab) Treatment Reduces the Burden of Disease in...
TOKYO Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin) today announced the publication of new data highlighting the sustained benefits of treatment with CRYSVITA® (burosumab) in adults with X-linked...
View ArticleClik here to view.
Organon推出公益广告，旨在引发关于意外怀孕的全球讨论
新泽西州泽西市 (美国商业资讯)–女性健康跨国公司Organon (NYSE: OGN)推出公益广告(PSA)，旨在提高人们对世界各地超高意外怀孕率的认识，并引发全球讨论。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20210924005113/zh-CN/...
View Article